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Cyclocondensation reactions of a variety of 2-acyl-3-indoleacetic 
acid derivatives with (R)-phenylglycinol are studied. Successful
results  were  obtained  from  N-alkyl  keto  acid  derivatives. 
The resulting tetracyclic lactams provide straightforward access 
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Introduction 
The tetrahydro-β-carboline ring system is present in many 
naturally occurring compounds, either simple tetrahydro-β-
carboline alkaloids[1]  or more complex natural products bearing 
additional fused rings,[2] most of them displaying significant 
biological and pharmacological activities.[3] This heterocyclic ring 
system is also present in numerous bioactive alkaloid-related 
synthetic compounds, some of which have emerged as important 
targets for pharmaceutical research.[4]  
A common structural feature of the alkaloids and bioactive  
synthetic analogues containing the tetrahydro-β-carboline nucleus 
is the presence of a stereogenic center at the C–1 position. This has 
stimulated the development of a variety of enantioselective 
methods for the synthesis of 1-substituted tetrahydro-β-
carbolines.[5-9] 
In the context of our studies on the use of phenylglycinol-
derived lactams as building blocks for the enantioselective 
synthesis of susbstituted piperidines and complex piperidine- 
containing natural products,[10] we present here a practical synthetic 
route to enantiopure 1-substituted tetrahydro-β-carbolines. 
Results and Discussion 
In previous work we have demonstrated that lactam 1, easily 
accessible by a cyclocondensation reaction of methyl 2-formyl-3,4-
dimethoxyphenylacetate with (R)-phenylglycinol, provides general 
access to enantiopure 1-substituted tetrahydroisoquinoline 
alkaloids[11]  (Scheme 1). The key step of the synthetic sequence is 
a stereoselective Grignard reagent-promoted α-amidoalkylation 
reaction for the introduction of the substituent at the 















Scheme 1.  Enantioselective access to 1-substituted tetrahydroisoquinolines. 
Apparently, the extension of the above methodology to the 
enantioselective synthesis of 1-substituted tetrahydro-β-carbolines 
simply required using a 2-formyl-3-indoleacetic acid derivative in 
the generation of the starting lactam. However, attempts at 
cyclocondensation reactions of aldehydes 2a[12] and 2b[13] (C6H6, 
reflux, 48 h) with (R)-phenylglycinol resulted in failure, aldimines 
3a and 3b, respectively, being quantitatively formed instead 
(Scheme 2). Decarboxylation of the labile 3-indoleacetic acid 
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Scheme 2.  Attempted cyclocondensation reactions of 2-formyl-3-
indoleacetic acid derivatives with (R)-phenylglycinol.  
As an alternative but related approach to the target tetrahydro-β-
carbolines we focused our attention on cyclocondensation reactions 
from keto acids, which would directly afford 1-substituted 
derivatives, thus avoiding the need of a subsequent α-
amidoalkylation reaction. However, also unsuccessful were the 
cyclocondensation reactions from the N-unsubstituted 2-acyl-3-
indoleacetic acids 4a and 4b.[14] Decarboxylation was the only 
process   observed   under   the   usual   reaction  conditions[15]  (see  
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Scheme 3.  Attempted cyclocondensation reactions of N-unsubstituted and N-EWG protected 2-acyl-3-indoleacetic acids with (R)-phenylglycinol.  
 
Scheme 3), giving the respective  ketones  5a[16]  (60%) and  5b 
(90%), whereas amide 6a (43%) was generated when the 
cyclocondensation reaction from 4a was attempted at a lower 
temperature in the presence of Mukaiyama’s reagent[17] (2-chloro-
1-methylpyridinium iodide, CH2Cl2, Et3N, reflux, 16 h). 
Decarboxylation also occurred from the N-benzenesulfonyl 
derivative 4c,[18] giving a mixture of 2-acetylindole 5c[19]  (15%) 
and oxazolidine 7c (25%).  
To avoid the undesirable decarboxylation, we also tried 
cyclocondensation reactions starting from δ-keto esters instead of 
δ-keto acids, either N-unsubstituted (4d)[14] or N-protected with an 
electron-withdrawing group (4e,[20] 4f,[21] and 4g[22]). Unfortunately, 
under the usual reaction conditions most of the starting materials 
were recovered.  
In contrast, cyclocondensation reactions of 1-methyl-2-acetyl-3-
indoleacetic acid 8a[22] with (R)-phenylglycinol satisfactorily led 
(65% yield) to a single tetracyclic lactam 9a, whose configuration 
was unambiguously established by X-ray crystallographic 
analysis[23] (Scheme 4). Similar results were obtained from 
indoleacetic acids 8b[24] and 8c[25], which bear an easily removable 
benzyl substituent on the indole nitrogen. The resulting lactams 9b 
and 9c (configuration confirmed by X-Ray crystallographic 
analysis[23]) were envisaged as synthetic precursors of the 
tetrahydro-β-carboline alkaloids tetrahydroharman and 
komaroidine.   
For this purpose three synthetic steps were required: 
simultaneous reduction of the lactam carbonyl and reductive 
opening   of   the   oxazolidine   ring,   removal   of   the   benzylic  
 
Scheme 4.  Cyclocondensation reactions of N-alkyl-2-acyl-3-indoleacetic 
acids with (R)-phenylglycinol.  
substituent on the piperidine nitrogen, and debenzylation of the 
indole nitrogen. The best conditions for the first step were provided 
by alane, generated from LiAlH4 and AlCl3, at low temperature. 
Under these conditions, tetracyclic lactams 9a-c were 
stereoselectively reduced, with retention of configuration[26] (see 
Figure 1), to 1-substituted tetrahydro-β-carbolines 10a-c in good 
yield (Table 1). Other reducing agents (LiAlH4, NaBH4/I2, RedAl, 
or 9-BBN) gave less satisfactory results in terms of chemical yield 
and/or stereoselectivity (formation of minor amounts of the C–1 
epimer). In some cases, partially reduced products, i.e. 
oxazolidines 11 and tricyclic lactams 12, were isolated as 
byproducts. 
 
Figure 1. Retention of configuration in the reductive cleavage of the 
oxazolidine ring. 
 
Table 1. Reduction of tetracyclic lactams 9. 
 
Starting lactam R1 R2 Reducing Agent Product (yield) 
9a Me Me AlCl3/LiAlH4
[a] 10a (94%) 
   LiAlH4 
[b] 10a (80%) 
   NaBH4/I2
[c]
 10a (55%), 1-epi-10a (28%)
[d] 
   RedAl
[e] 10a (16%), 11a (58%), 12a (18%) 
9b Bn Me AlCl3/LiAlH4
[a] 
10b (60%) 
   LiAlH4
[b] 10b (41%) 
   RedAl[e] 10b (<5%), 11b (<5%), 12b (10%) 
   9-BBN[f] 10b (24%) 
9c Bn n-Pr AlCl3/LiAlH4
[a] 10c (70%) 
   LiAlH4
[b] 10c (73%), 1-epi-10c (<5%) 
   NaBH4/I2
[c] 10c (76%), 1-epi-10c (9%) 
[a] THF, –33 ºC, 2 h; r.t., 2 h. [b] THF, r. t., 16 h (9a), 2 h (9b), 48 h (9c). [c] THF, reflux, 16 h. [d] Calculated  by GC-MS analysis                                     
of a purified mixture. [e] CH2Cl2, 0 ºC, 3 h (9a), 1h (9b). [f] THF, reflux, 4 h.  
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Finally, removal of the phenylethanol moiety from 10a by 
debenzylation with hydrogen in the presence of Pd(OH)2 led to (–)-
N-methyltetrahydroharman[27] (Scheme 5). On the other hand, 
debenzylation of the indole nitrogen of 10b and 10c with Na in liq. 
NH3,
 followed by hydrogenolysis of the resulting N-unsubstituted 
indoles 13 led to the alkaloids (+)-tetrahydroharman[28] and (+)-
komaroidine.[29]  The latter was converted to the alkaloid (-)-N-
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Scheme 5.  Synthesis of 1-substituted tetrahydro-β-carboline alkaloids.  
Conclusions 
In contrast with many other cyclocondensation reactions 
between δ-oxoacid derivatives and (R)-phenylglycinol leading to 
oxazolopiperidone lactams,[10] the cyclocondensation reaction fails 
from 2-formyl-3-indoleacetic acid derivatives 2 and from N-
unsubstituted or N-EWG-protected 2-acyl-3-indoleacetic acid  
derivatives 4. However, N-alkyl substituted 2-acyl-3-indoleacetic 
acids 8 can be satisfactorily converted to the corresponding 
tetracyclic lactams 9, thus providing easy access to enantiopure 1-
substituted tetrahydro-β-carbolines. Starting from indoles bearing 
an easily removable N-benzyl group, the strategy developed here 
can be applied to the enantioselective synthesis of N-unsubstituted 
tetrahydro-β-carboline alkaloids.  
Experimental Section 
General: Flash chromatography was carried out on SiO2 (silica gel 60, 
SDS, 0.04-0.06 mm). Melting points were taken with a Büchi apparatus and 
are uncorrected. Optical rotations were measured on Perkin-Elmer 241 
polarimeter. High resolution mass spectra (HMRS; LC/MSD TOF Agilent 
Technologies) were performed by Centres Científics i Tecnològics de la 
Universitat de Barcelona. Microanalyses (Carlo Erba 1106 analyzer) were 
performed by Centre d’Investigació i Desenvolupament (CSIC), Barcelona. 
Only noteworthy IR absorptions (cm-1; Perkin-Elmer 1600) are listed. NMR 
spectra were recorded with either a Varian Gemini-300 (300 and 75.4, MHz 
for 1H and 13C, respectively) or Mercury-400 (400 and 100.6, MHz for 1H 




Data for new 2-acyl-3-indoleacetic acid derivatives 2, 4, 8 and indoles 3, 
5-7: 
 
1-Benzyl-2-formyl-3-indoleacetic acid (2b): 1H NMR (400 MHz, CDCl3, 
25ºC): δ = 4.12 (s, 2H, CH2), 5.76 (s, 2H, NCH2), 7.04 (d, J = 7.2 Hz, 2H, 
H-o), 7.18-7.23 (m, 4H, H-5, H-6 and H-m), 7.33-7.37 (m, 2H, H-7 and H-
p), 7.73 (d, J = 7.6 Hz, 1H, H-4), 10.1 (s, 1H, CHO) ppm. 13C NMR (100.6 
MHz, CDCl3, 25ºC): δ =
 29.8 (CH2), 47.8 (NCH2), 111.0 (C-7), 120.9 (C-3), 
121.2 (C-6), 121.3 (C-4), 126.4 (C-o), 126.5 (C-3a), 127.4 (C-5), 127.7 (C-
p), 128.6 (C-m), 131.2 (C-2), 137.5 (C-i), 139.2 (C-7a), 176.0 (CO2H), 




indoleacetate (3a): IR (KBr): υ = 1454, 1493, 1534, 1664, 1736, 2924 cm-1. 
1H NMR (400 MHz, CDCl3, 25ºC): δ = 3.63 (dd, J = 11.2, 8.8 Hz, 1H, 
CH2OH), 3.66 (s, 3H, CH3), 3.71 (dd, J = 11.2, 4.4 Hz, 1H, CH2OH), 3.99 
(d, J = 16.0 Hz, 1H, CH2CO2CH3), 4.10 (d, J = 16.0 Hz, 1H, CH2CO2CH3), 
4.32 (dd, J = 8.8, 4.4 Hz, 1H, CHAr), 5.82 (d, J = 16.8 Hz, 1H, NCH2), 
5.95 (d, J = 16.8 Hz, 1H, NCH2), 6.96 (d, J = 7.2 Hz, 2H, ArH), 7.15-7.34 
(m, 11H, H-4, H-6, H-7 and ArH), 7.69 (d, J = 7.6 Hz, 1H, H-5), 8.59 (s, 
1H, CHN) ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ =  30.3 
(CH2CO2CH3), 47.9 (NCH2), 52.1 (CH3), 68.0 (CH2OH), 77.5 (CHAr), 
110.0 (C-7), 114.2 (C-3), 119.5 (C-5), 120.4 (C-6), 124.8 (C-4), 125.8 (C-
o), 127.0 (C-3a), 127.1 (C-p), 127.2 (C-o), 127.3 (C-p), 128.4 (C-m), 128.6 
(C-m), 131.0 (C-2), 138.5 (C-i), 138.6 (C-7a), 140.4 (C-i), 152.7 (CHN), 
171.8 (CO) ppm. HRMS calcd for C27H26N2O3 [M + H]




methylindole (3b): 1H NMR (400 MHz, CDCl3, 25ºC): δ = 2.47 (s, 3H 
CH3), 3.59 (dd, J = 11.2, 8.8 Hz, 1H, CH2OH), 3.66 (dd, J = 11.2, 4.0 Hz, 
1H, CH2OH), 4.26 (dd, J = 8.8, 4.0 Hz, 1H, CHAr), 5.88 (d, J = 16.4 Hz, 
1H, NCH2), 6.06 (d, J = 16.4 Hz, 1H, NCH2), 6.94 (d, J = 8.4 Hz, 2H, ArH), 
7.08-7.33 (m, 11H, H-4, H-6, H-7 and ArH), 7.63 (d,  J = 8.0 Hz, 1H, H-5), 
8.65 (s, 1H, CHN) ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ =
 8.7 
(CH3), 48.1 (NCH2), 68.0 (CH2OH), 77.5 (CHAr), 109.6 (C-7), 119.3 (C-3), 
119.6 (C-5), 119.9 (C-6), 124.8 (C-4), 125.7 (C-o), 126.8 (C-p), 127.0 (C-
o), 127.2 (C-p), 127.5 (C-3a), 128.3 (C-m), 128.4 (C-m), 129.8 (C-2), 139.0 
(C-i), 139.4 (C-7a), 140.8 (C-i), 152.9 (CHN) ppm. HRMS calcd for 
C25H24N2O [M + H]
+: 369.1961; found 369.1955. 
 
2-Acetyl-1-(benzenesulfonyl)-3-indoleacetic acid (4c): 1H NMR (400 
MHz, CD3Cl3, 25ºC): δ = 2.79 (s, 3H, CH3), 3.71 (s, 2H, CH2), 7.24-7.30 
(m, 3H, H-6 and ArH), 7.38-7.48 (m, 3H, H-Ind and ArH), 7.51 (d, J = 7.6 
Hz, 2H, ArH), 8.07 (d, J = 8.4 Hz, 1H, H-7) ppm. 13C NMR (400 MHz, 
CD3Cl3, 25ºC): δ = 31.3 (CH2), 31.9 (CH3), 116.5 (C-7), 121.1 (C-4), 125.6 
(C-6), 126.9 (Co), 128.5 (C-5), 128.8 (Cm), 130.3 (C-3a), 134.3 (Cp), 134.5 
(C-2), 137.8 (C-i), 138.3  (C-7a), 172.1 (COOH), 197.1 (C=O). HRMS 
calcd for C18H15NO5S [M + H]
+: 358.0744; found 358.0746.  
 
Ethyl 2-acetyl-1-(tert-butoxycarbonyl)-3-indoleacetate (4e): IR (KBr): υ 
= 1453, 1565, 1693, 1735, 2933, 2980 cm-1. 1H NMR (400 MHz, CDCl3, 
25ºC): δ = 1.23 (t, J = 6.8 Hz, 3H, CH3CH2), 1.65 [s, 9H, C(CH3)3], 2.51 (s, 
3H, COCH3), 3.79 (s, 2H, CH2), 4.12 (q, J = 6.8 Hz, 2H, CO2CH2CH3), 
7.29 (m, 1H, H-5), 7.41 (ddd, J = 8.5, 6.8, 1.2 Hz, 1H, H-6), 7.58 (d, J = 8.5 
Hz, 1H, H-7), 8.09 (d, J = 8.5 Hz, 1H, H-4) ppm. 13C NMR (100.6 MHz, 
CDCl3, 25ºC): δ = 14.1 (CH3CH2), 27.9 (COCH3), 29.7 (CH2), 31.2 
[C(CH3)3], 61.1 (CO2CH2CH3), 85.4 [C(CH3)3], 115.4 (C-7), 116.6 (C-3), 
120.3 (C-6), 123.5 (C-4), 126.8 (C-5), 128.3 (C-3a), 136.0 (C-2), 136.4 (C-
7a), 150.0 (NCO), 170.2 (CO2CH2CH3), 194.9 (COCH3) ppm. HRMS calcd  
for C19H23NO5  [M + H]
+: 346.1648; found 346.1648.  
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Methyl 2-acetyl-1-tosyl-3-indoleacetate (4f): IR (KBr): υ = 1364, 1595, 
1684, 1743 cm-1. 1H NMR (400 MHz, CDCl3, 25ºC): δ = 2.25 (s, 3H, 
COCH3), 2.72 (s, 3H, CH3Ar), 3.61 (s, 3H, CO2CH3), 3.72 (s, 2H, CH2), 
7.05 (d, J = 8.4 Hz, 1H, H-7), 7.22 (t, J = 8,0 Hz, 1H, H-5), 7.38 (d, J = 7.6 
Hz, 1H, H-6), 7.46 (s, 2H, ArH), 7.48 (s, 2H, ArH), 8.02 (d, J = 8.4 Hz, 1H, 
H-4) ppm. 13C NMR (75.4 MHz, CDCl3, 25ºC): δ = 21.4 (COCH3), 29.6 
(CH2), 32.1 (CH3Ar), 52.1 (CO2CH3), 115.9 (C-7), 120.6 (C-6), 121.9 (C-3), 
124.9 (C-4), 127.0 (C-o), 127.3 (C-5), 129.3 (C-m), 130.4 (C-2), 132.3 (C-
3a), 136.9 (C-i), 138.0 (C-i), 145.0 (C-7a), 169.8 (CO2CH3), 195.8 
(COCH3) ppm. HRMS calcd for C20H19NO5S [M + H]
+: 386.1056; found: 
386.1051.  
 
Methyl 2-acetyl-1-(methoxycarbonyl)-3-indoleacetate (4g): 1H NMR 
(300 MHz, CDCl3, 25ºC): δ = 2.48 (s, 3H, COCH3), 3.68 (s, 3H, CO2CH3), 
3.83 (s, 2H, CH2), 4.04 (s, 3H, NCO2CH3), 7.31 (t, J = 7.2 Hz, 1H, H-5), 
7.44 (t, J = 7.2 Hz, 1H, H-6), 7.57 (d, J = 7.5 Hz, 1H, H-7), 8.07 (d, J = 7.5 
Hz, 1H, H-4) ppm. 13C NMR (75.4 MHz, CDCl3, 25ºC): δ = 29.5 (CH2), 
30.6 (COCH3), 52.2 (NCO2CH3), 54.2 (CO2CH3), 115.4 (C-7), 117.8 (C-3), 
120.3 (C-4), 123.8 (C-5), 127.1 (C-6), 128.8 (C-3a), 135.6 (C-2), 136.4 (C-
7a), 151.4 (NCO2), 170.5 (CO2CH3),  194.4 (COCH3) ppm.  
 
2-Butanoyl-3-methylindole (5b): 1H NMR (300 MHz, CDCl3, 25ºC): δ = 
0.98 (t, J = 7.5 Hz, 3H, CH2CH3), 1.75 (m, 2H, CH2CH3), 2.57 (s, 3H, CH3), 
2.85 (t, J = 7.2 Hz, 2H, CH2CH2CH3), 7.05 (ddd, J = 8.0, 6.0, 1.2 Hz, 1H, 
H-5), 7.25-7.31 (m, 2H, H-6, H-7), 7.61 (d, J = 8.0 Hz, 1H, H-4), 9.00 (s, 
1H, NH) ppm. 13C NMR (75.4 MHz, CDCl3, 25ºC): δ = 11.3 (CH2CH3), 
14.1 (CH3), 17.7 (CH2CH3), 43.0 (CH2CH2CH3), 112.0 (C-7), 118.0 (C-3), 
120.0 (C-4), 121.2 (C-6), 126.3 (C-5), 129.0 (C-3a), 132.6 (C-2), 136.1 (C-
7a), 193.5 (CO) ppm.  
 
2-Acetyl-N-[(R)-2-hydroxy-1-phenylethyl]-3-indoleacetamide (6a): IR 
(KBr): υ = 1531, 1649, 2933, 3013, 3308 cm-1. 1H NMR (300 MHz, CDCl3, 
25ºC): δ = 2.35 (s, 3H, COCH3), 3.72 (dd, J = 11.5, 6.6 Hz, 1H, CH2OH), 
3.80 (dd, J = 11.5, 4.2 Hz, 1H, CH2OH), 4.06 (s, 2H, CH2CONH), 5.06 (m, 
1H, CHAr), 7.10-7.29 (m, 8H, H-5, H-6, H-7, ArH), 7.69 (d, J = 8.4 Hz, 1H, 
H-4), 9.40 (s, 1H, NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 27.9 
(CH3), 33.6 (CH2), 55.9 (CHAr), 66.4 (CH2OH), 112.4 (C-7), 120.8 (C-4), 
121.0 (C-6), 121.1 (C-5), 122.0 (C-3), 126.7 (C-o), 127.8 (C-m), 128.7 (C-
p), 132.0 (C-3a), 132.3 (C-2), 136.1 (C-i), 138.7 (C-7a), 171.3 (CONH), 
191.3 (COCH3) ppm. EM (IQ
+): m/z (%): 336 (1); 305 (32); 200 (37); 172 
(100); 158 (23); 144 (12); 130 (61); 104 (42); 77 (37); 51 (7). 
 
3-Methyl-2-[(R)-2-methyl-4-phenyl-1,3-oxazolidin-2-yl]indole (7a): 1H 
NMR (400 MHz, CDCl3, 25ºC): δ = 1.81 (s, 3H, OCCH3), 2.39 (s, 3H, 
CH3), 4.28 (dd, J = 8.5, 6.8 Hz, 1H, CH2), 4.75 (t, J = 8.5 Hz, 1H, CH2), 
5.28 (t, J = 7.2 Hz, 1H, CHAr), 7.30-7.44 (m, 7H, H-5, H-6, ArH), 7.54 (d, 
J = 8.0 Hz, 1H, H-7), 7.93 (d, J = 7.6 Hz, 1H, H-4) ppm. 13C NMR (100.6 
MHz, CDCl3, 25ºC): δ = 8.4 (CH3), 22.5 (OCCH3), 59.8 (CHAr), 74.3 
(CH2), 95.3 (OCCH3), 110.3 (C-3), 112.9 (C-7), 119.8 (C-6), 122.9 (C-4), 
124.7 (C-5), 125.7 (C-m), 127.6 (C-p), 128.7 (C-o), 130.1 (C-3a), 134.9 (C-
i), 139.8 (C-2), 155.4 (C-7a) ppm. EM (IQ+):  m/z (%):  (M+ + 27) 319 
(100); 320 (28); 318 (9). 
 
1-(Benzenesulfonyl)-3-methyl-2-[(R)-2-methyl-4-phenyl-1,3-oxazolidin-
2-yl]indole (7c): 1H NMR (300 MHz, CDCl3, 25ºC): δ = 2.14 (s, 3H, CH3), 
2.39 (s, 3H, CH3), 3.99 (m, 2H, CH2), 5.04 (m, 1H, CHAr), 7.20-7.56 (m, 
11H, ArH), 7.80 (d, J =  7.2 Hz, 2H, ArH), 8.02 (d, J  =  8.1 Hz, 1H, H-7) 
ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 9.16 (CH3), 21.8 (CH3), 
67.3 (CHAr), 68.9 (CH2), 115.4 (C-7), 119.8 (C-6), 124.3 (C-4), 127.1 (C-
o), 127.6 (C-m), 128.5 (C-5), 128.7 (C-p), 132.0 (C-3a), 133.8 (C-2) ppm.  
 
2-Acetyl-1-benzyl-3-indoleacetic acid (8b): IR (KBr): υ = 1611, 1732, 
3440 cm-1. 1H NMR (300 MHz, CDCl3, 25ºC): δ = 2.54 (s, 3H, COCH3), 
4.07 (s, 2H, CH2), 5.63 (s, 2H, NCH2), 6.96 (d, J = 7.5 Hz, 2H, H-o), 7.14-
7.34 (m, 6H, H-5, H-6, H-7, H-m, H-p), 7.69 (d, J = 7.8 Hz, 1H, H-4), 
12.23 (COOH) ppm. 13C-NMR (75.4 MHz, CDCl3, 25ºC): δ = 30.7 
(COCH3), 31.7 (CH2), 48.5 (NCH2), 110.8 (C-7), 115.1 (C-3), 120.7 (C-4), 
121.1 (C-6), 126.0 (C-o), 126.4 (C-5), 126.8 (C-3a), 127.1 (C-p), 128.5 (C-
m), 134.3 (C-2), 137.9 (C-i), 138.6 (C-7a), 176.0 (CO2H), 192.7 (COCH3) 
ppm. HRMS calcd for C19H17NO3 [M + Na]
+: 330.1101; found 330.1093.  
 
1-Benzyl-2-butanoyl-3-indoleacetic acid (8c): IR (KBr): υ = 1652, 3436 
cm-1. 1H NMR (400 MHz, CDCl3, 25ºC): δ = 0.83 (t, J = 7.6 Hz, 3H, 
CH3CH2), 1.64 (sext, 2H, J = 7.6 Hz, CH3CH2), 2.83 (t, J = 7.6 Hz, 2H, 
CH2CH2CH3), 4.07 (s, 2H, CH2), 5.62 (s, 2H, NCH2), 6.97 (d, J = 6.8 Hz, 
2H, H-o), 7.18-7.34 (m, 6H, H-5, H-6, H-7, H-m, H-p), 7.73 (d, J = 8.0 Hz, 
1H, H-4) ppm. 13C-NMR (75.4 MHz, CDCl3, 25ºC): δ = 13.6 (CH3CH2), 
17.9 (CH3CH2), 32.0 (CH2), 44.5 (CH2CH2CH3), 48.7 (NCH2), 110.8 (C-7), 
114.4 (C-3), 120.7 (C-4), 121.2 (C-6), 126.0 (C-o), 126.3 (C-5), 126.8 (C-
3a), 127.3 (C-p), 128.6 (C-m), 135.2 (C-2), 137.7 (C-i), 138.7 (C-7a), 175.2 
(CO2H), 196.7 (COCH3) ppm. HRMS calcd for C21H21NO3 [M + Na]
+: 
358.1417; found 358.1414.  
 
 (3R,11bS)-11,11b-Dimethyl-5-oxo-3-phenyl-3,5,6,11b-tetrahydro-2H-
oxazolo[3’,2’:1,2]pyrido[3,4-b]indole (9a): (R)-phenylglycinol (355 mg, 
2.6 mmol) was added to a solution of keto acid 8a (500 mg, 2.2 mmol) in 
benzene (35 mL). The mixture was heated at reflux for 18 h with azeotropic 
elimination of water produced by a Dean-Stark apparatus. The resulting 
suspension was cooled and concentrated. Flash chromatography (8:2 
hexane–EtOAc) afforded lactam 9a  (475 mg, 65%) as a white solid;  m. p. 
166–168oC (hexane-EtOAc). [α]22D = – 62.9 (c = 1.0, CHCl3). IR (KBr): υ 
= 1382, 1470, 1661, 2927 cm-1. 1H NMR (400 MHz, CDCl3, 25ºC): δ = 
1.70 (s, 3H, CH3), 3.82 (s, 2H, H-6), 3.88 (s, 3H, NCH3), 4.19 (dd, J = 8.4, 
6.8 Hz, 1H, H-2), 4.65 (t, J = 8.4 Hz, 1H, H-2), 5.49 (t, J = 8.0 Hz, 1H, H-
3), 7.16 (t, J = 8.0 Hz, 1H, H-9), 7.26-7.40 (m, 7H, H-8, H-10, ArH), 7.52 
(d, J = 8.0 Hz, 1H, H-7) ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 
26.8 (CH3), 30.4 (C-6), 30.8 (NCH3), 58.5 (C-3), 70.7 (C-2), 91.9 (C-11b), 
104.6 (C-6a), 109.5 (C-10), 118.9 (C-7), 119.8 (C-9), 122.7 (C-8), 125.6 
(C-m), 127.3 (C-p), 128.7 (C-o), 130.5 (C-6b), 133.5 (C-11a), 138.4 (C-i), 
139.7 (C-10a), 168.3 (CO) ppm. HRMS calcd for C21H20N2O2 [M + H]
+: 
333.1597; found 333.1592. C21H20N2O2 (332.15): calcd. C 75.88, H 6.06, N 
8.43; found C 75.96, H 6.13, N 8.37.  
 
(3R,11bS)-11-Benzyl-11b-methyl-5-oxo-3-phenyl-3,5,6,11b-tetrahydro-
2H-oxazolo[3’,2’:1,2]pyrido[3,4-b]indole (9b): Operating as in the above 
preparation of 9a, from keto acid 8b (150 mg, 0.5 mmol) and (R)-
phenylglycinol 87 mg (0.6 mmol) in benzene (8 mL), lactam 9b (121 mg, 
60%) was obtained after flash chromatography (9:1 to 8:2 hexane–EtOAc). 
[α]22D = – 96.6 (c = 1.0, CHCl3). IR (KBr): υ = 1382, 1454, 1495, 2924 cm
-1. 
1H NMR (400 MHz, CDCl3, 25ºC): δ = 1.60 (s, 3H, CH3), 3.85 (d, J = 20.1 
Hz, 1H, H-6), 3.90 (d, J = 20.1 Hz, 1H, H-6), 4.14 (dd, J = 9.0, 6.6 Hz, 1H, 
H-2), 4.53 (dd, J = 9.0, 8.4 Hz, 1H, H-2), 5.50 (t, J = 7.5 Hz, 1H, H-3), 5.55 
(d, J = 16.8 Hz, 1H, NCH2), 5.65 (d, J = 16.8 Hz, 1H, NCH2), 7.05 (d, J = 
7.2 Hz, 2H, H-m), 7.14-7.38 (m, 11H, H-8, H-9, H-10, ArH), 7.56 (d, J = 
6.4 Hz, 1H, H-7) ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 27.5 
(CH3), 30.5 (C-6), 48.0 (NCH2), 58.4 (C-3), 70.7 (C-2), 92.1 (C-11b), 105.3 
(C-6a), 110.6 (C-10), 118.9 (C-7), 120.1 (C-8), 123.0 (C-9), 125.1 (C-6b), 
125.6 (C-o), 126.1 (C-m), 127.1 (C-p), 127.3 (C-p), 128.5 (C-o), 128.6 (C-
m), 133.9 (C-i), 137.8 (C-10a), 138.0 (C-i), 139.6 (C-11a), 168.3 (CO) ppm. 
HRMS calcd for C27H24N2O2 [M + H]
+ 409.1911; found 409.1905. 
 
(3R,11bS)-11-Benzyl-5-oxo-3-phenyl-11b-propyl-3,5,6,11b-tetrahydro-
2H-oxazolo[3’,2’:1,2]pyrido[3,4-b]indole (9c): Operating as in the 
preparation of 9a, from keto acid 8c (180 mg, 0.54 mmol) and (R)-
phenylglycinol 93 mg (0.64 mmol) in benzene (10 mL), lactam 9c (156 mg, 
66%) was obtained as a yellow oil after flash chromatography (95:5 
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hexane–EtOAc). [α] 22D = – 96.4 (c = 1.01, CHCl3). IR (KBr): υ = 1453, 
1663, 2927, 2960 cm-1. 1H NMR (400 MHz, CDCl3, 25ºC): δ = 0.55 (t, J = 
7.2 Hz, 3H, CH3), 0.84-0.91 (m, 1H, CH2CH3), 1.25-1.37 (m, 1H, CH2CH3), 
1.60 (td, J = 13.4, 4.8 Hz, 1H, CH2CH2CH3), 1.80 (td, J = 13.4, 4.0 Hz, 1H, 
CH2CH2CH3), 3.87 (s, 2H, H-6), 4.19 (dd, J = 8.8, 7.2 Hz, 1H, H-2), 4.59 (t, 
J = 8.8 Hz, 1H, H-2), 5.51 (d, J = 17.2 Hz, 1H, NCH2), 5.57 (t, J = 7.6 Hz, 
1H, H-3), 5.68 (d, J = 17.2 Hz, 1H, NCH2), 7.03 (d, J = 7.6 Hz, 2H, H-m), 
7.15-7.40 (m, 11H, H-8, H-9, H-10, ArH), 7.54 (m, 1H, H-7) ppm. 13C 
NMR (100.6 MHz, CDCl3, 25ºC): δ =
 13.1 (CH3), 17.2 (CH2CH3), 30.8 (C-
6), 40.9 (CH2CH2CH3), 48.0 (CH2C6H5), 58.4 (C-3), 70.5 ( C-2), 94.9 (C-
11b), 106.9 (C-6a), 110.6 (C-10), 119.0 (C-7), 120.1 (C-9), 123.1 (C-8), 
124.9 (C-6b), 125.3 (C-m), 125.8 (C-o), 127.1 (C-p), 127.3 (C-p), 128.5 (C-
o), 128.6 (C-m), 131.5 (C-i), 137.9 (C-i), 138.2 (C-11a), 140.1 (C-10a), 
169.1 (CO) ppm. HRMS calcd for C29H28N2O2 [M + H]




tetrahydropyrido[3,4-b]indole (10a): LiAlH4 (151 mg, 4 mmol) was 
slowly added to a suspension of AlCl3 (173 mg, 1.3 mmol) in THF (12 mL) 
at 0 °C and the mixture was stirred for 3.5 h. After cooling to – 33°C, a 
solution of lactam 9a (202 mg, 0.6 mmol) in THF (17 mL) was slowly 
added. The stirring was continued at – 33°C for 2 h and at room 
temperature for 2 h. After cooling to 0°C, the reaction was quenched with 
MeOH (2 ml) and water (2 mL). The aqueous layer was extracted with 
EtOAc, and the combined organic extracts were dried and concentrated. 
Flash chromatography (hexane to 7:3 hexane–EtOAc) of the residue 
afforded compound 10a as a pale yellow oil (181.5 mg, 94%). [α]22D = – 
36.8 (c = 1.0, CHCl3).  IR (KBr): υ = 1469, 2930, 3408 cm
-1. 1H NMR (400 
MHz, CDCl3, 25ºC): δ = 1.50 (d, J = 6.8 Hz, 3H, CH3), 2.51 (dt, J = 15.2, 
4.0 Hz, 1H, H-4), 2.70 (dddd, J =  15.2, 5.2, 4.8, 0.8 Hz, 1H, H-4), 2.83 
(ddd, J = 13.2, 4.8, 4.0 Hz, 1H, H-3), 3.18 (ddd, J = 13.2, 9.2, 5.2 Hz, 1H, 
H-3), 3.60 (s, 3H, NCH3), 3.84 (dd, J = 8.0, 2.4 Hz, 1H, CH2OH), 3.89 (dd, 
J = 8.0, 6.8 Hz, 1H, CH2OH), 3.91 (q, J = 6.8 Hz, 1H, CHAr), 4.30 (q, J = 
6.8 Hz, 1H, H-1), 7.08 (ddd, J = 8.2, 6.8, 1.0 Hz, 1H, H-6), 7.18 (ddd, J = 
8.2, 7.0, 1.2 Hz, 1H, H-7), 7.25-7.38 (m, 6H, H-8, ArH), 7.45 (dt, J = 7.2, 
1.0 Hz, 1H, H-5) ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 19.5 (C-4), 
19.9 (CH3), 29.6 (NCH3), 40.4 (C-3), 48.4 (C-1), 63.4 (CH2OH), 64.6 
(CHAr), 106.8 (C-4a), 108.6 (C-8), 117.9 (C-5), 118.8 (C-6), 120.9 (C-7), 
126.6 (C-4b), 127.6 (C-p), 128.3 (C-m), 128.5 (C-o), 137.1 (C-9a), 
137.5(C-i), 139.4 (C-8a) ppm. HRMS calcd for C21H24N2O [M + H]
+: 
321.1961; found 321.1954.  
 
(R)-9-Benzyl-2-[(R)-2-hydroxy-1-phenylethyl]-1-methyl-1,2,3,4-
tetrahydropyrido[3,4-b]indole (10b): Operating as in the above reduction 
of 9a, starting from a solution of lactam 9b (165 mg, 0.4 mmol) in THF (11 
mL), LiAlH4 (100 mg, 2.6 mmol), and AlCl3 (117 mg, 0.88 mmol) in THF 
(8 mL), tetrahydro-β-carboline 10b (95 mg, 60%) was obtained after flash 
chromatography (7:3 hexane–EtOAc). [α] 22D = – 80.1 (c  1.1, CHCl3). 
1H 
NMR (400 MHz, CDCl3, 25ºC): δ = 1.42 (d, J = 6.8 Hz, 3H, CH3), 2.51 
(ddd, J = 16.0, 4.4, 2.8 Hz, 1H, H-4), 2.70 (ddd, J =  16.0, 10.4, 6.0 Hz, 1H, 
H-4), 2.84 (m, 1H, H-3), 3.19 (ddd, J = 14.0, 10.4, 5.2 Hz, 1H, H-3), 3.63 
(m, 1H, CH2OH), 3.76 (t, J = 4.8 Hz, 1H, CH2OH), 4.15 (m, 1H, H-1), 5.14 
(d, J = 16.8 Hz, 1H, NCH2), 5.34 (d, J = 16.8 Hz, 1H, NCH2), 6.93 (d, J = 
7.6 Hz, 1H, H-5), 7.06-7.29 (m, 12H, H-6, H-8, ArH), 7.49 (m, 1H, H-7) 
ppm.  13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 19.2 (C-4), 20.3 (CH3), 
40.0 (C-3), 46.5 (CH2C6H5), 48.4 (C-1), 63.3 (CH2OH), 64.7 (CHAr), 107.6 
(C-4a), 109.4 (C-8), 118.1 (C-5), 119.3 (C-6), 121.3 (C-7), 125.9 (C-o), 
126.9 (C-4b), 127.3 (C-p), 127.6 (C-p), 128.3 (C-m), 128.4 (C-m), 128.7 
(C-o), 137.1 (C-8a), 137.4 (C-i), 137.6 (C-9a), 139.3 (C-i) ppm. EM (IQ+): 




tetrahydropyrido[3,4-b]indole (10c):  Operating as in the preparation of 
10a, from a solution of lactam 9c (100 mg, 0.23 mmol) in THF (5 mL), 
LiAlH4 (57 mg, 1.5 mmol), and AlCl3 (67 mg, 0.5 mmol) in THF (6.5 mL), 
tetrahydro-β-carboline 10c (68 mg, 70%) was obtained after flash 
chromatography (95:5 hexane–EtOAc). [α] 22D = – 82.5 (c 1.0, CHCl3). IR 
(KBr): υ = 1453, 1647, 2955 cm-1. 1H NMR (400 MHz, CDCl3, 25ºC): δ = 
0.91 (t, J = 7.2 Hz, 3H, CH3), 1.50-1.63 (m, 4H, CH2CH2CH3), 2.38 (ddd, J 
= 15.0, 4.0, 2.0 Hz,  1H, H-4), 2.66 (ddd, J = 15.0, 10.8, 5.6 Hz, 1H, H-4), 
2.78 (dd, J = 14.0, 4.0 Hz, 1H, H-3), 3.18 (ddd, J = 14.0, 10.8, 5.2 Hz, 1H, 
H-3), 3.49 (dd, J = 12.4, 4.8 Hz, 2H, CH2OH), 3.68 (t, J = 4.8 Hz, 1H, H-1), 
4.04 (d, J = 9.2 Hz, 1H, CHAr), 5.17 (d, J = 17.0 Hz, 1H, NCH2), 5.40 (d, J 
= 17.0 Hz, 1H, NCH2), 6.98 (d, J = 6.8 Hz, 2H, ArH), 7.10-7.14 (m, 2H, H-
6, H-7), 7.23-7.30 (m, 9H, H-8, ArH), 7.48 (d, J = 7.2 Hz, 1H, H-5) ppm. 
13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 13.9 (CH3),
 17.7 (C-4), 19.7 
(CH2CH3), 36.9 (CH2CH2CH3), 39.6 (C-3), 46.7 (NCH2), 52.5 (C-1), 63.8 
(CH2OH), 64.6 (CHAr), 107.9 (C-4a), 109.4 (C-8), 118.1 (C-5), 119.1 (C-
6), 121.3 (C-7), 126.0 (C-o), 127.5 (C-p), 128.3 (C-m), 128.5 (C-4b), 128.8 
(C-m), 136.6 (C-i), 137.1 (C-8a), 137.9 (C-i), 140.5 (C-9a) ppm. HRMS 
calcd for C29H32N2O [M + H]
+: 425.2587; found 425.2583. 
 
Data for 1-epi derivatives and partially reduced compounds 11, 12: 
 
(S)-2-[(R)-2-Hydroxy-1-phenylethyl]-1,9-dimethyl-1,2,3,4-
tetrahydropyrido[3,4-b]indole (1-epi-10a): 1H NMR (300 MHz, CDCl3, 
25ºC, from a mixture 10a:epi-10a): δ = 1.36 (d, J = 6.9 Hz, 3H, CH3), 2.40-
2.48 (m, 2H, H-4), 2.90-3.02 (m, 1H, H-3), 3.31 (m, 1H, H-3), 3.40 (s, 3H, 
NCH3), 3.79 (dd, J = 6.0, 4.5 Hz, 1H, CH2OH), 4.30 (m, 1H, H-1), 7.05-
7.48 (m, 9H, ArH) ppm. 13C NMR (75.4 MHz, CDCl3, 25ºC): δ =
 18.4 (C-
4), 19.2 (CH3), 29.1 (NCH3), 39.7 (C-3), 49.1 (C-1), 63.9 (CH2OH), 65.3 
(CHAr), 106.2 (C-4a), 108.6 (C-8), 117.9 (C-5), 118.7 (C-6), 120.8 (C-7), 
126.5 (C-4b), 127.5 (C-p), 128.2 (C-m), 128.3 (C-o), 137.1 (C-9a), 
137.5(C-i), 141.2 (C-8a) ppm.  
 
(S)-9-Benzyl-2-[(R)-2-hydroxy-1-phenylethyl]-1-propyl-1,2,3,4-
tetrahydropyrido[3,4-b]indole (1-epi-10c): [α] 22D = – 75.8 (c  0.9, 
CHCl3). 
1H NMR (400 MHz, CDCl3, 25ºC): δ = 0.68 (t, J = 7.5 Hz, 3H, 
CH3), 1.15-1.30 (m, 2H, CH2CH2CH3), 1.54-1.61 (m, 1H, CH2CH2CH3), 
1.73-1.79 (m, 1H, CH2CH2CH3), 2.64 (dm, 1H, J = 16.0 Hz, H-4), 3.07 
(ddd, J = 16.0, 10.4, 7.2 Hz, 1H, H-4), 3.41 (m, 2H, H-3), 3.47 (t, J = 9.2 
Hz, 1H, H-1), 3.74 (dd, J = 6.0, 3.2 Hz, 1H, CHAr), 3.84 (dd, J = 11.0, 3.2 
Hz, 1H, CH2OH), 4.03 (dd, J = 11.0 , 6.0 Hz, 1H, CH2OH), 4.91 (d, J = 
16.8 Hz, 1H, NCH2), 4.96 (d, J = 16.8 Hz, 1H, NCH2), 6.79 (m, 2H, ArH), 
7.10-7.20 (m, 11H, ArH, H-Ind), 7.53 (m, 1H, H-8) ppm. 13C NMR (100.6 
MHz, CDCl3, 25ºC): δ = 13.9 (CH3),
 17.4 (C-4), 19.8 (CH2CH3), 36.9 
(CH2CH2CH3), 39.6 (C-3), 46.4 (NCH2), 53.2 (C-1), 64.4 (CH2OH), 64.7 
(CHAr), 107.0 (C-4a), 109.6 (C-8), 118.0 (C-5), 119.2 (C-6), 121.3 (C-7), 
126.1 (C-o), 127.2 (C-p), 127.6 (C-4b), 128.8 (C-p), 128.6 (C-m), 128.7 (C-
m), 136.9 (C-i),  137.0 (C-8a), 137.6 (C-i), 140.9 (C-9a) ppm. EM (IQ+): 
m/z %:  424 (1); 393 (10); 381 (100); 288 (16); 261 (39); 169 (20); 103 
(16); 91 (95). 
 
(3R,11bS)-11,11b-Dimethyl-3-phenyl-3,5,6,11b-tetrahydro-2H-oxazolo 
[3’,2’:1,2]pyrido[3,4-b]indole (11a): [α]22D = – 96.6 (c = 1.0, CHCl3). IR 
(KBr): υ = 1382, 1470, 2927, 2934 cm-1. 1H NMR (400 MHz, CDCl3, 
25ºC): δ = 1.78 (s, 3H, CH3), 2.44 (dd, J = 16.0, 4.8 Hz, 1H, H-6), 2.91 
(ddd, J = 16.0, 12.0, 5.6 Hz, 1H, H-6), 3.09 (dd, J = 14.4, 5.6 Hz, 1H, H-5), 
3.17 (ddd, J = 14.4, 12.0, 5.2 Hz, 1H, H-5), 3.70 (t, J = 7.6 Hz, 1H, H-2), 
3.80 (s, 3H, NCH3), 3.97 (t, J = 7.6 Hz, 1H, H-2), 4.17 (t, J = 7.6 Hz, 1H, 
H-3), 7.04 (ddd, J = 14.4, 7.2, 0.8 Hz, 1H, H-9), 7.16 (ddd, J = 14.4, 7.5, 
1.2 Hz, 1H, H-8), 7.23-7.28 (m, 5H, ArH), 7.43 (d, J = 7.5 Hz, 1H, H-7) 
ppm. 13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 16.2 (C-6), 26.7 (CH3), 
30.8 (NCH3), 40.9 (C-5), 61.3 (C-3), 72.8 (C-2), 92.1 (C-11b), 107.2 (C-6a), 
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109.0 (C-10), 118.7 (C-7), 119.0 (C-9), 121.9 (C-8), 126.0 (C-6b), 127.7 
(C-p), 127.5 (C-o), 127.8 (C-p), 136.0 (C-i), 137.4 (C-11a), 140.1 (C-10a) 
ppm. HRMS calcd for C21H22N2O [M + H]
+: 319.1810; found 319.1817.  
 
(R)-2-[(R)-2-Hydroxy-1-phenylethyl]-1,9-dimethyl-3-oxo-1,2,3,4-
tetrahydropyrido[3,4-b]indole (12a): [α]22D = + 70.8 (c = 0.5, CHCl3). IR 
(KBr): υ = 1469, 1621, 2929, 3382 cm-1. 1H NMR (400 MHz, CDCl3, 
25ºC): δ = 1.38 (d, J = 6.4 Hz, 3H, CH3), 3.51 (s, 3H, NCH3), 3.70 (d, J = 
19.2 Hz, 1H, H-4), 3.82 (d, J = 19.2 Hz, 1H, H-4), 4.11 (dd, J = 12.0, 3.5 
Hz, 1H, CH2OH), 4.37 (dd, J = 12.0, 7.2 Hz, 1H, CH2OH), 4.83 (dd, J = 7.2, 
3.5 Hz, 1H, CHAr), 7.07-7.09 (m, 1H, H-6), 7.15-7.38 (m, 6H, H-7, H-8, 
ArH), 7.43 (d, J = 8.0 Hz, 1H, H-5) ppm. 13C NMR (100.6 MHz, CDCl3, 
25ºC): δ = 22.3 (CH3), 29.6 (C-4), 30.8 (NCH3), 53.0 (C-1), 64.3 (CHCH2), 
66.1 (CH2OH), 103.9 (C-4a), 109.2 (C-8), 118.3 (C-5), 119.7 (C-6), 122.0 
(C-7), 125.0 (C-4b), 127.3 (C-p), 128.2 (C-m), 128.7 (C-o), 134.0 (C-9a), 
136.7 (C-8a), 137.9 (C-i), 171.6 (CO) ppm. HRMS calcd for C21H22N2O2 
[M + H]+: 335.1759; found 335.1749.  
 
 (R)-9-Benzyl-2-[(R)-2-hydroxy-1-phenylethyl]-1-methyl-3-oxo-1,2,3,4-
tetrahydropyrido[3,4-b]indole (12b): [α]22D = + 18.25 (c = 1.2, CHCl3). 
1H NMR (400 MHz, CDCl3, 25ºC): δ = 1.29 (d, J = 6.4 Hz, 3H, CH3), 3.68-
3.79 (m, 2H, H-4, OH), 3.92 (m, 1H, H-4), 4.03 (dt, J = 12.0, 4.3 Hz, 1H, 
CH2OH), 4.26 (dt, J = 12.0, 7.4 Hz, 1H, CH2OH), 4.46 (q, J = 6.4 Hz, 1H, 
H-1), 4.88 (dd, J = 7.4, 4.3 Hz, 1H, CHAr), 5.09 (d, J = 16.8 Hz, 1H, 
NCH2), 5.29 (d, J = 16.8 Hz, 1H, NCH2), 6.85-6.88 (m, 1H, H-5), 7.14-7.28 
(m, 12H, H-6, H-7, ArH), 7.53-7.56 (m, 1H, H-8) ppm. 13C NMR (100.6 
MHz, CDCl3, 25ºC): δ = 22.4 (CH3), 31.1 (C-4), 46.9 (CH2C6H5), 52.6 (C-
1),  64.0 (CH2OH), 65.5 (CHCH2), 105.2 (C-4a), 109.8 (C-8), 118.4 (C-5), 
120.0 (C-6), 122.3 (C-7), 125.4 (C-4b), 125.8 (C-o), 127.5 (C-o), 127.5 (C-
p), 127.8 (C-p), 128.7 (C-m), 128.9 (C-m), 134.5 (C-8a), 136.6 (C-i), 136.9 
(C-9a), 139.3 (C-i), 171.4 (CO) ppm. HRMS calcd for C27H26N2O2 [M + 
H]+: 411.2067; found 411.2071.  
 
(R)-2-[(R)-2-Hydroxy-1-phenylethyl]-1-methyl-1,2,3,4-
tetrahydropyrido[3,4-b]indole (13b): Into a three–necked round–
bottomed equipped with a coldfinger condenser charged with dry ice-
acetone was condensed 30 mL of  NH3 at – 78°C. The temperature was 
raised to – 33 °C, and a solution of amine 10b (90 mg, 0.23 mmol) in THF 
(2 mL) was added. Then, sodium metal was added in small portions until 
the blue color persisted. The mixture was stirred at – 33 °C for 1 min. The 
reaction was quenched by addition of solid NH4Cl until the blue color 
disappeared. The mixture was stirred at rt for 4h. The resulting residue was 
digested at rt with CH2Cl2, poured into water, and extracted with CH2Cl2. 
The combined organic extracts were dried and concentrated. Flash 
chromatography (8:2 hexane–EtOAc) of the residue afforded 13b (54 mg, 
77%) as a white solid. [α] 22D = + 21.2 (c = 0.99, CHCl3). IR (KBr): υ = 
1454, 1644, 3440 cm-1. 1H NMR (400 MHz, CDCl3, 25ºC): δ = 1.59 (d, J = 
6.6 Hz, 3H, CH3), 2.40 (ddd, J = 12.3, 8.4, 5.1 Hz, 1H, H-3), 2.67 (m, 2H, 
H-4), 3.25 (dt, J = 12.3, 4.2 Hz, 1H, H-3), 3.77 (dd, J = 10.5, 4.8 Hz, 1H, 
CH2OH), 4.10 (dd, J = 10.5, 9.0 Hz, 1H, CH2OH), 4.11 (q, J = 6.6 Hz, 1H, 
H-1), 4.25 (dd, J = 9.0, 4.8 Hz, 1H, CHAr), 7.06-7.15 (m, 2H, H-6, H-7), 
7.24-7.35 (m, 6H, H-8, ArH), 7.43 (m, 1H, H-5), 7.65 (brs, 1H, NH) ppm. 
13C NMR (100.6 MHz, CDCl3, 25ºC): δ = 19.7 (CH3), 21.4 (C-4), 42.2 (C-
3), 50.5 (C-1), 60.9 (CH2OH), 62.8 (CHAr), 108.3 (C-4a), 110.7 (C-8), 
118.1 (C-5), 119.4 (C-7), 121.5 (C-6), 127.0 (C-4b), 128.0 (C-p), 128.4 (C-
o), 129.0 (C-m), 136.0 (C-i), 136.1 (C-8a), 136.2 (C-9a) ppm. HRMS calcd 
for  C20H22N2O [M + H]
+: 307.1805; found 307.1790. 
 
(R)-2-[(R)-2-Hydroxy-1-phenylethyl]-1-propyl-1,2,3,4-tetrahydropyrido 
[3,4-b]indole (13c): Operating as in the above preparation of 13b (reaction 
time 10 min), from 10c (190 mg, 0.45 mmol) in THF (2 mL), sodium, and 
liquid NH3 (30 mL), compound  13c (105 mg, 70%) was obtained  as a 
white solid after flash chromatography (95:5 hexane–EtOAc). [α] 22D = + 
2.1 (c = 1.0, CHCl3). IR (KBr): υ = 1454, 1626, 2957, 3406 cm
-1. 1H NMR 
(400 MHz, CDCl3, 25ºC): δ = 0.95 (t, J = 7.6 Hz, 3H, CH3), 1.30 (m, 1H, 
CH2CH3), 1.53 (m, 1H, CH2CH3), 1.72 (m, 1H, CH2CH2CH3), 2.07 (m, 1H, 
CH2CH2CH3),  2.50-2.68 (m, 2H, H-4), 2.65 (m, 1H, H-3), 3.25 (m, 1H, H-
3), 3.80 (dd, J = 11.3, 5.2 Hz, 1H, CH2OH), 4.01 (t, J = 11.3 Hz, 1H, 
CH2OH), 4.10 (m, 1H, CHAr), 7.03 (ddd, J = 7.2, 7.2 ,1.2 Hz, 1H, H-6), 
7.07 (ddd, J = 8.0, 8.0, 1.6 Hz, 1H, H-7), 7.32 (m, 6H, H-8, ArH), 7.42 (d, J 
= 7.6 Hz, 1H, H-5), 7.71 (s, 1H, NH) ppm. 13C NMR (100.6 MHz, CDCl3, 
25ºC): δ = 14.4 (CH3), 18.1 (CH2CH3), 35.5 (CH2CH2CH3), 41.5 (C-3), 
54.6 (C-1), 62.1 (CH2OH), 63.4 (CHAr), 109.1 (C-4a), 110.6 (C-8), 117.3 
(C-5), 119.3 (C-7), 121.4 (C-6), 127.1 (C-4b), 128.0 (C-p), 128.4 (C-o) 
128.9 (C-m), 135 (C-i), 135.9 (C-8a), 137.3 (C-9a) ppm. HRMS calcd for  
C22H26N2O [M + H]
+: 335.2118; found 335.2121. 
 
(–)-(R)-N-Methyltetrahydroharman: A solution of 10a (164 mg, 0.51 
mmol) in MeOH (7.5 mL) containing Pd(OH)2 (16.4 mg) was hydrogenated 
at room temperature for 40 h. The catalyst was removed by filtration, and 
washed by hot MeOH. The solvent was evaporated, and the residue was 
purified by preparative TLC (SiO2 deactivated with TEA, 95:5 CH2Cl2–
MeOH) to obtain N-methyltetrahydroharman as an amorphous yellow solid 
(76 mg, 75%). [α] 22D = –28.6 (c 1.0, CHCl3). IR (KBr): υ = 1468, 1712, 
2925; 2961, 2460 cm-1. 1H NMR (400 MHz, CDCl3, 25ºC): δ = 1.42 (d, J = 
6.5 Hz, 3H, CH3), 2.03 (brs, 1H, NH), 2.65 (t, J = 5.2 Hz, 2H, H-4), 3.07 
(dt, J = 13.0, 4.4 Hz, 1H, H-3), 3.15 (ddd, J =  13.0, 13.0, 6.4 Hz, 1H, H-3), 
3.55 (s, 3H, NCH3), 4.15 (q, J = 6.5 Hz, 1H, H-1), 7.01 (ddd, J = 8.0, 8.0, 
1.2 Hz, 1H, H-5), 7.11 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H, H-7), 7.19 (d, J = 8.0 
Hz, 1H, H-6), 7.41 (d, J = 7.6 Hz, 1H, H-8) ppm.  13C NMR (100.6 MHz, 
CDCl3, 25ºC): δ = 20.9 (CH3), 22.8 (C-4), 29.8 (NCH3), 39.2 (C-3), 46.3 
(C-1), 107.2 (C-4a), 108.6 (C-8), 118 (C-7), 118.9 (C-5), 121.1 (C-6), 126.9 
(C-4b), 136.9 (C-8a), 138.5 (C-9a) ppm. HRMS calcd for C13H16N2 [M + 
H]+: 201.1386; found 201.1385.  
 
(+)-(R)-Tetrahydroharman: Operating as in the above preparation of N-
methyltetrahydroharman, from compound 13b (66 mg, 0.21 mmol) and 
Pd(OH)2 (6.6 mg) in MeOH (3 mL),  (R)-tetrahydroharman was obtained 
(28 mg, 71%) as an amorphous yellow solid after purification with 
preparative TLC (SiO2 deactivated with TEA, 90:10 CH2Cl2–MeOH). 
[α]22D = + 49.6 (c  0.5, EtOH). IR (KBr): υ = 1453, 1725, 2853, 2925 cm
-1.  
1H NMR (400 MHz, CD3OD, 25ºC): δ = 1.50 (d, J = 6.8 Hz, 3H, CH3), 
2.66-2.86 (m, 2H, H-4), 3.02 (ddd, J = 14.8, 9.6, 5.2 Hz, 1H, H-3), 3.32 (m, 
1H, H-3), 4.20 (q, J = 6.8 Hz, 1H, H-1), 6.97 (t, J = 8.0 Hz, 1H, H-5), 7.05 
(d, J = 8.0 Hz, 1H, H-8), 7.29 (d, J = 8.0 Hz, 1H, H-7), 7.38 (d, J = 8.0 Hz, 
1H, H-6) ppm. 13C NMR (100.6 MHz, CD3OD, 25ºC): δ = 19.8 (CH3), 22.3 
(C-4), 43.4 (C-3), 49.7 (C-1), 107.8 (C-4a), 111.9 (C-8), 118.6 (C-5), 119.8 
(C-7), 122.2 (C-6), 128.4 (C-4b), 136.6 (C-8a), 137.8 (C-9a) ppm. HRMS 
calcd for  C12H14N2 [M + H]
+: 187.1230; found 187.1228.  
 
(+)-(R)-Komaroidine: Operating as in the preparation of N-
methyltetrahydroharman, from 13c (80 mg, 0.24 mmol) and Pd(OH)2 (20 
mg) in MeOH (4 mL), (+)-(R)-komaroidine was obtained (37 mg, 73%)  as 
an amorphous pale yellow solid after  preparative TLC (SiO2 deactivated 
with TEA, 98:2 CH2Cl2–MeOH). [α] 
22
D = + 83.6 (c = 0.91, EtOH). IR 
(KBr): υ = 1454, 1622, 2927, 3282, 3410 cm-1. 1H NMR (400 MHz, 
CD3OD, 25ºC): δ = 0.99 (t, J = 7.2 Hz, 3H, CH3), 1.46-1.60 (m, 2H, 
CH2CH3), 1.62-1.71 (m, 1H, CH2CH2CH3), 1.80-1.88 (m, 1H, CH2CH2CH3), 
2.74 (m, 2H, H-4), 3.02 (ddd, J = 13.0, 8.0, 5.6 Hz, 1H, H-3), 3.35 (dt, J = 
13.0, 4.0 Hz, 1H, H-3), 4.07 (ddd, J = 6.4, 4.0, 2.0 Hz, 1H, H-1), 7.08 (ddd, 
J = 7.6, 7.6, 0.8 Hz, 1H, H-6), 7.14 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H, H-7), 
7.29 (t, J = 1.2 Hz, 1H, H-8), 7.31 (t, J = 0.8 Hz, 1H, H-5) ppm. 13C NMR 
(100.6 MHz, CD3OD, 25ºC): δ = 14.2 (CH3), 19.1 (CH2CH3), 22.7 (C-4), 
37.2 (CH2CH2CH3), 42.6 (C-3), 52.4 (C-1), 108.9 (C-4a), 110.6 (C-8), 
118.0 (C-5), 119.3 (C-6), 121.4 (C-7), 127.5 (C-4b), 135.6 (C-8a), 136.4 
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(C-9a) ppm. HRMS calcd for C14H18N2 [M + H]
+: 215.1543; found 
215.1542.  
 
(–)-(R)-Acetylkomaroidine: Acetyl chloride (20 µl, 0.28 mmol) was 
slowly added (0°C) to a solution of (+)-(R)-komaroidine (30 mg, 0.14 
mmol) and TEA (59 µl, 0.42 mmol) in CH2Cl2 (1 mL), and the mixture was 
stirred at room temperature for 2h. Saturated aqueous NaHCO3 solution 
was added and the aqueous layer was extracted with CH2Cl2. The combined 
organic extracts were dried and concentrated. Purification of the resulting 
oil by preparative TLC (SiO2 deactivated with DEA, 7:3 hexane–EtOAc) 
gave acetylkomaroidine (31 mg, 87%) as a pale yellow oil. [α]22D = – 93.4  
(c  1.0, CHCl3). IR (KBr): υ = 1449, 1618, 2957, 3272 cm
-1. 1H NMR (400 
MHz, CD3OD, 25ºC, two rotamers): major rotamer: δ = 0.96 (t, J = 7.6 Hz, 
CH3), 1.43-1.56 (m, CH2CH3), 1.75-1.87 (m, CH2CH2CH3), 2.24 (s, 
CH3CO), 2.77-2.82 (m, H-4), 3.50 (ddd, J = 13.6, 11.2, 4.8 Hz, H-3), 3.99 
(ddd, J = 13.6, 4.8, 1.2 Hz, H-3), 5.79 (dd, J = 8.4, 5.2 Hz, H-1), 7.07 (td, J 
= 8.0, 1.2 Hz, H-7), 7.13 (td, J = 7.2, 1.2 Hz, H-6), 7.30 (d, J = 7.6 Hz, H-8), 
7.43 (d, J = 7.2 Hz, H-5), 8.35 (brs, NH) ppm; minor rotamer: δ = 0.98 (t, J 
= 7.6 Hz, CH3), 1.43-1.56 (m, CH2CH3), 1.75-1.87 (m, CH2CH2CH3), 2.17 
(s, CH3CO), 2.65-2.75 (m, H-4), 2.98 (ddd, J = 12.0, 12.0, 5.2 Hz, H-4), 
4.86 (t, J = 7.6 Hz, H-1), 4.94 (dd, J = 12.8, 5.6 Hz, H-3), 5.79 (dd, J = 8.4, 
5.2 Hz, H-1), 7.05-7.15 (m, ArH), 7.48 (d, J = 7.6 Hz, H-5), 8.15 (brs, NH) 
ppm. 13C NMR (100.6 MHz, CD3OD, 25ºC): major rotamer: δ = 14.1 (CH3), 
19.6 (CH2CH3), 21.9 (CH3CO), 22.0 (C-4), 36.8 (CH2CH2CH3), 41.0 (C-3), 
48.9 (C-1), 107.2 (C-4a), 110.9 (C-8), 117.8 (C-5), 119.4 (C-7), 121.6 (C-6), 
126.6 (C-4b), 134.8 (C-8a), 136.0 (C-9a), 169.7 (CO) ppm; minor rotamer: 
δ = 14.2 (CH3), 19.5 (CH2CH3), 21.0 (CH3CO), 21.9 (C-4), 35.9 
(CH2CH2CH3), 37.7 (C-3), 52.0 (C-1), 109.3 (C-4a), 110.8 (C-8), 118.3 (C-
5), 119.7 (C-7), 122.0 (C-6), 126.7 (C-4b), 133.6 (C-8a), 136.1 (C-9a), 
169.7 (CO) ppm. HRMS calcd for C16H20N2O [M + H]
+: 257.1648; found 
257.1646.  
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A short synthetic route to enantiopure 1-
substituted tetrahydro-β-carbolines is 
reported. The key step is a stereoselective 
cyclocondensation   reaction  between   
an  N-alkyl-2-acyl-3-indoleacetic   acid   
and (R)-phenylglycinol. Subsequent 
reductive processes and debenzylation of 
the indole nitrogen provide access to Na-
unsubstituted alkaloids, such as 
tetrahydroharman and komaroidine. 
 M. Amat,* F. Subrizi, V. Elias, N. Llor, 
E. Molins, J. Bosch …….... Page No. – 
Page No. 
Cyclocondensation Reactions of 2-Acyl-
3-indoleacetic Acid Derivatives with 
Phenylglycinol. Enantioselective 
Synthesis of 1-Substituted Tetrahydro-β-
carboline Alkaloids 
Keywords: Alkaloids / 
Tetrahydroisoquinolines / Lactams / 
Phenylglycinol / α-Amidoalkylation 
Submitted to the European Journal of Organic Chemistry 10 
 
